Appropriate Prescribing of Specialist Infant Formulae

Introduction

Specialist infant formulae (SIF) are nutritionally customised products designed for babies with specific medical or physiological needs that cannot be met by standard breastmilk substitutes. While the prevalence of SIF use varies between countries, inappropriate prescribing can lead to unnecessary expense, reduced breastfeeding rates, and potential health risks. This page outlines a systematic, evidencebased approach to prescribing SIF, aimed at clinicians, dietitians, and allied health professionals.

When to Consider Specialist Infant Formulae

The decision to prescribe a specialist formula should be based on clear clinical criteria. Common indications include:

• Preterm infants (34weeks gestation) or very low birth weight (<1500g)
• Congenital metabolic disorders (e.g., phenylketonuria, galactosaemia)
• Severe cowmilk protein allergy (CMPA) or multiple food protein intolerance
• Gastrooesophageal reflux disease (GORD) unresponsive to standard measures
• Rare conditions such as eosinophilic oesophagitis, short bowel syndrome, or malabsorption syndromes

For most infants, standard infant formula or, preferably, breastmilk will meet nutritional requirements.

Clinical Assessment Before Prescribing

A structured assessment helps differentiate between infants who truly need SIF and those who may benefit from alternative strategies.

1. Detailed History feeding patterns, growth trajectory, family history of allergies, and any prior formula trials.
2. Physical Examination assess signs of malnutrition, dermatitis, gastrointestinal symptoms, and developmental milestones.
3. Growth Monitoring plot weight, length/height, and head circumference on appropriate growth charts (WHO or local standards).
4. Laboratory Tests (when indicated) serum amino acids, electrolytes, specific metabolic markers, or allergy testing.

Choosing the Right Specialist Formula

When a specialist formula is deemed necessary, select the most specific product that addresses the identified need. The following table summarises common categories.

Prescribe the smallest effective volume and reassess frequently; many conditions improve with age, allowing a stepdown to standard formula.

Monitoring & Followup

Effective monitoring ensures that the infant achieves expected growth and that the formula remains appropriate.

• Weight gain of 15g/day for term infants and 20g/day for preterm infants during the first month of therapy.
• Remeasure growth parameters every 24weeks until stability, then at routine wellchild visits.
• Document any adverse reactions gastrointestinal upset, rash, or feeding intolerance.
• Consider gradual weaning to standard formula when clinical criteria are met (e.g., resolution of allergy symptoms, adequate weight gain).

Education & Support for Families

Parents often feel overwhelmed by specialist formulas, which can be more expensive and require specific preparation.

• Demonstrate correct reconstitution using measured water and a clean bottle.
• Provide written instructions and contact details for urgent queries.
• Discuss the importance of continuing breastfeeding if possible, as complementary feeding can improve outcomes.
• Refer families to community dietitians for ongoing nutritional counselling.

Ethical & Cost Considerations

Specialist formulas are frequently more costly than standard options. Ethical prescribing requires:

• Evidencebased justification for each prescription.
• Awareness of insurance coverage or public health funding criteria.
• Transparent discussion with families about cost, alternatives, and duration of therapy.

Whenever possible, seek formulas that are locally available to reduce delivery delays and expenses.

Conclusion

Appropriate prescribing of specialist infant formulae balances clinical necessity, evidencebased choice, vigilant monitoring, and family support. By following a structured pathwayassessment, targeted selection, and regular reviewclinicians can optimise infant health while minimising unnecessary interventions and costs.